NCT02014623View on ClinicalTrials.gov

Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL

Enrollment

51

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

November 15, 2019

Conditions

Allergic Rhinitis

Interventions

OTHER

Grass pollen sublingual immunotherapy tablet

DRUG

Control

Trial Locations (1)

3181

Department of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital- Bayside Health, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayside Health

OTHER_GOV